We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Women continued to excrete THC in breast milk for up to 6 weeks — and possibly longer — after abstaining from using marijuana, according to a study published in JAMA Pediatrics.
Erica M. Wymore, MD, MPH, a specialist in neonatal and perinatal medicine at Children’s Hospital Colorado, and colleagues performed a prospective, observational pharmacokinetic study of women with prenatal marijuana use who delivered infants between Nov. 1, 2016, and June 30, 2019.
Source: Shutterstock.com
A total of 394 women were screened for inclusion. Of these women, 105 were eligible and 25 were enrolled.
Criteria for study inclusion was an intention to breastfeed and marijuana abstention for 6 weeks. Study participants reported on substance use patterns, as well as provided maternal plasma and breast milk samples two to five times per week. Each sample was frozen for periodic batched analysis.
Of the 25 women enrolled, only 12 who self-reported abstinence from marijuana were actually abstinent based on plasma analysis results.
An analysis was performed on 402 matched plasma-milk samples. THC was the predominant compound found in the samples, with negligible concentrations of hydrophilic THC metabolites.
Every participant had detectable THC in their breast milk samples throughout the study. Within the first week postpartum for women who abstained, median THC concentrations were 3.2 ng/mL (interquartile range [IQR] = 1.2-6.8). This increased to 5.5 ng/mL (IQR = 4.4-16) at 2 weeks and declined to 1.9 ng/mL (IQR = 1.1-4.3) after 6 weeks.
The authors reported that the milk-to-plasma partition coefficient for THC was 6:1 (IQR = 3.8:1-8.1:1).
“To limit THC effects on fetal brain development and promote safe breastfeeding, it is critical to emphasize marijuana abstention both early in pregnancy and postpartum,” the authors wrote.